A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX ® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19
Conditions: SARS CoV 2 Infection; Influenza, Human Interventions: Biological: BIMERVAX; Biological: SIIV Sponsor: Hipra Scientific, S.L.U Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
